Adjuvant Chemotherapy for Gastric Cancer with S-1, an Oral Fluoropyrimidine-Reference-Cited by-同舟云学术

Adjuvant Chemotherapy for Gastric Cancer with S-1, an Oral Fluoropyrimidine

Published:2007-11 Issue:18 Volume:357 Page:1810-1820
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Sakuramoto Shinichi,Sasako Mitsuru,Yamaguchi Toshiharu,Kinoshita Taira,Fujii Masashi,Nashimoto Atsushi,Furukawa Hiroshi,Nakajima Toshifusa,Ohashi Yasuo,Imamura Hiroshi,Higashino Masayuki,Yamamura Yoshitaka,Kurita Akira,Arai Kuniyoshi

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa072252

Cited by 2175 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combination of S-1 and the oral ATR inhibitor ceralasertib is effective against pancreatic cancer cells;Cancer Chemotherapy and Pharmacology;2024-09-14

2. Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY;Journal of Clinical Oncology;2024-09-01

3. Comparison of surgical outcomes and postoperative nutritional parameters between subtotal and proximal gastrectomy in patients with proximal early gastric cancer;Annals of Gastroenterological Surgery;2024-08-28

4. Comparison of treatment strategies based on clinical and pathological nodal status in resectable gastric adenocarcinoma;Journal of Surgical Oncology;2024-08-27

5. Correlation between the C-reactive protein (CRP)-albumin-lymphocyte (CALLY) index and the prognosis of gastric cancer patients after gastrectomy: a systematic review and meta-analysis;Surgery Today;2024-08-19